MedPath

Fentanyl

Generic Name
Fentanyl
Brand Names
Abstral, Actiq, Duragesic, Effentora, Fentora, Instanyl, Lazanda, Sublimaze, Subsys, PecFent
Drug Type
Small Molecule
Chemical Formula
C22H28N2O
CAS Number
437-38-7
Unique Ingredient Identifier
UF599785JZ
Background

Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia. Fentanyl is related to other opioids like morphine and oxycodone.

Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin. In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths). Opioid overdoses kill an average of 11 Canadians daily.

Fentanyl was FDA approved in 1968.

Indication

Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.

Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.

Associated Conditions
Cancer Related Pain (Breakthrough Pain), Severe, Chronic Pain
Associated Therapies
Anesthetic premedication therapy, Anesthetics Agent, General Anesthesia, Induction of anesthesia therapy, Maintenance of anesthesia therapy, Regional Anesthesia therapy

Rapip Study: Clinical Trial on Remifentanyl for Analgesia and Sedation of Ventilated Neonates and Infants

Phase 3
Completed
Conditions
Mechanical Ventilation
Interventions
First Posted Date
2007-01-08
Last Posted Date
2010-06-25
Lead Sponsor
University of Cologne
Target Recruit Count
24
Registration Number
NCT00419601
Locations
🇩🇪

Clinic for Paediatrics, University of Cologne Kerpener Str. 62, Cologne, Germany

Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children

Phase 3
Completed
Conditions
Pain
Interventions
First Posted Date
2006-11-30
Last Posted Date
2010-12-13
Lead Sponsor
The Hospital for Sick Children
Target Recruit Count
64
Registration Number
NCT00405444
Locations
🇨🇦

The Hospital for Sick Children, Toronto, Ontario, Canada

Acute Neurological ICU Sedation Trial (ANIST)

Phase 2
Completed
Conditions
Sedation
Interventions
Drug: Fentanyl/Dexmedetomidine
Drug: Fentanyl/Propofol
Drug: Fentanyl
First Posted Date
2006-10-20
Last Posted Date
2019-05-16
Lead Sponsor
Johns Hopkins University
Target Recruit Count
35
Registration Number
NCT00390871
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Phase 3
Completed
Conditions
Cancer
First Posted Date
2006-08-10
Last Posted Date
2012-05-07
Lead Sponsor
Nycomed
Target Recruit Count
100
Registration Number
NCT00362583
Locations
🇩🇰

Nycomed, Roskilde, Denmark

Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)

Phase 2
Completed
Conditions
Cancer
Pain
First Posted Date
2006-06-28
Last Posted Date
2012-05-07
Lead Sponsor
Nycomed
Target Recruit Count
150
Registration Number
NCT00345735
Locations
🇩🇰

Nycomed, Roskilde, Denmark

Effect of Dexmedetomidine Upon Sleep Postoperatively

Phase 4
Withdrawn
Conditions
Sleep
First Posted Date
2006-06-06
Last Posted Date
2014-07-14
Lead Sponsor
Duke University
Registration Number
NCT00333632
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates

Phase 3
Completed
Conditions
Congenital Cystic Adenomatoid Malformation
Interventions
First Posted Date
2006-02-03
Last Posted Date
2009-09-16
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
32
Registration Number
NCT00286143
Locations
🇺🇸

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Postoperative Pain After Orthopedic Surgery: Does it Help to Give Fentanyl Before Start of Remifentanil Based Anesthesia?

Phase 3
Completed
Conditions
Pain, Postoperative
First Posted Date
2005-10-18
Last Posted Date
2011-07-06
Lead Sponsor
Ullevaal University Hospital
Target Recruit Count
100
Registration Number
NCT00241332
Locations
🇳🇴

Ullevaal University Hospital, Oslo, Norway

A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With Osteoarthritis

Phase 4
Completed
Conditions
Osteoarthritis
Arthritis
First Posted Date
2005-10-12
Last Posted Date
2011-05-17
Lead Sponsor
Janssen Pharmaceutica N.V., Belgium
Target Recruit Count
418
Registration Number
NCT00236366

Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain

Phase 4
Terminated
Conditions
Pain
First Posted Date
2005-10-12
Last Posted Date
2011-05-17
Lead Sponsor
Janssen Cilag S.A.S.
Target Recruit Count
34
Registration Number
NCT00236327
© Copyright 2025. All Rights Reserved by MedPath